Nov 12, 2025, 01:01 AM by User Not Found

Bio-IT World | Though gender equity efforts in research have made strides, progress has plateaued. Roughly two-thirds of pivotal clinical trials leading to the U.S. Food and Drug Administration (FDA) drug approvals now include women at rates proportional to their disease burden, but the problem is fundamental issues in not considering female biology.

Nov 12, 2025, 01:00 AM by User Not Found

Bio-IT World | Though gender equity efforts in research have made strides, progress has plateaued. Roughly two-thirds of pivotal clinical trials leading to the U.S. Food and Drug Administration (FDA) drug approvals now include women at rates proportional to their disease burden, but the problem is fundamental issues in not considering female biology.

Nov 11, 2025, 08:11 AM by

* Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins * Broadens Amperia’s applications across recombinant protein research, screening, and development * Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November

Nov 11, 2025, 08:11 AM by

MadeAi launched new capabilities in its MadeAi(TM) GenAI-powered platform for life science evidence synthesis and report generation - capabilities that expedite global value dossier (GVD) and Joint Clinical Assessment (JCA), and streamline literature review from protocol creation to regulatory-ready reporting.

Nov 11, 2025, 01:01 AM by User Not Found

Bio-IT World | Watchmaker Genomics has launched TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. By capturing multiple biological dimensions in a single assay, TAPS+ delivers a richer, more comprehensive view of tumor biology.

Nov 6, 2025, 10:06 AM by User Not Found

Bio-IT World | Antibody-drug conjugates (ADCs) are among the most promising and complex therapeutics in modern oncology. The global ADC market is growing at an extraordinary pace. Yet, this promise comes with complexity. Multi-step conjugations, long processing times, highly potent raw materials, and stringent quality requirements pose significant manufacturing challenges.

Nov 6, 2025, 07:55 AM by

Nov 6, 2025, 07:55 AM by

Nov 5, 2025, 01:00 AM by User Not Found

Bio-IT World | For millions of patients prescribed drugs with a narrow therapeutic window, safe dosing depends on therapeutic drug monitoring. But outside of hospital labs equipped with specialized machines and trained staff, monitoring drug concentrations in real time has been largely out of reach. DNA nanotechnology may hold the key to bringing this critical capability to the point of care—and even into patients’ homes.

Nov 4, 2025, 08:47 AM by

Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion

Nov 4, 2025, 08:47 AM by

DoseMe, a global leader in model-informed precision dosing (MIPD) software and a portfolio company of Fairlong Capital, today announced the acquisition of Firstline, a leading clinical decision support platform utilized worldwide. Firstline enables clinicians to rapidly access local, evidence-based infectious disease treatment guidance, susceptibility patterns, and antimicrobial stewardship (AMS) resources. The combination of DoseMe and Firstline creates a single, connected experience from therapy selection through personalized dosing, giving clinicians a faster path to optimal care.

Nov 4, 2025, 08:46 AM by

Nov 4, 2025, 01:01 AM by User Not Found

Bio-IT World | Pacific Biosciences announced a chemistry upgrade and SMRT cell reuse capability last month at the American Society of Human Genetics (ASHG) meeting. CEO Christian Henry said the moves targeted dramatic price reductions for customers and to compete with short-read sequencing.

Nov 3, 2025, 08:52 AM by

Aylward Enterprises, a recognized leader in oral solid dose (OSD) packaging automation, highlights the TCM Tablet Counter, engineered to provide 100% count verification and reject-on-the-fly performance for pharmaceutical, nutraceutical, and healthcare packaging lines.

Nov 3, 2025, 08:52 AM by

Lonza has announced that it has signed an agreement to acquire Redberry.

Oct 30, 2025, 08:36 AM by

Oct 30, 2025, 08:36 AM by

EazeBio has announced a strategic partnership with the University of California, Santa Cruz to advance and commercialize a groundbreaking instrument-free diagnostic platform.

Oct 30, 2025, 01:01 AM by User Not Found

Bio-IT World | NVIDIA CEO Jensen Huang used NVIDIA’s GTC 2025 keynote to share his vision for the convergence of quantum computing and artificial intelligence, while revealing staggering demand for the company’s next-generation Grace Blackwell architecture that signals a fundamental shift in how the world computes.

Oct 29, 2025, 05:36 AM by User Not Found

Bio-IT World | SandboxAQ releases AQCat25-EV2, a new quantitative AI model trained on the AQCat25 dataset; Illumina launches BioInsight, a new business within Illumina developed to meet industry demand for deeper biologic insights; Thermo Fisher Scientific introduces the Applied Biosystems SwiftArrayStudio Microarray Analyzer; and more.

Oct 28, 2025, 09:08 AM by

Spaarne Gasthuis, a top clinical teaching hospital serving part of the Greater Amsterdam region, is fully digitizing its pathology practice with Concentriq® AP-Dx* from Proscia®. With this software platform, the hospital will empower its pathologists to play an even more significant role in guiding personalized treatment decisions for hundreds of thousands of patients each year.